Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent Logan

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
JAMA Oncology|December 13, 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development StudyEhab Atallah, Brent Logan, Min Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Blood and marrow transplant clinical trials network state of the Science Symposium 2014Frederick R Appelbaum, Claudio Anasetti, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Transplantation and Cellular Therapy|October 10, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research AnalysisNosha Farhadfar, Stephanie Bo-Subait, Gabrielle Schmidt, et al.
British Journal of Haematology|April 7, 2009
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantationVoravit Ratanatharathorn, Brent Logan, Dan Wang, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Bone Marrow Transplantation|November 20, 2019
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adultsNavneet S Majhail, Lih-Wen Mau, Pintip Chitphakdithai, et al.
Transplantation and Cellular Therapy|April 6, 2021
Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell DonationsSandhya R Panch, Brent Logan, Jennifer A Sees, et al.
Blood|December 15, 2018
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseasesMonica S Thakar, Larisa Broglie, Brent Logan, et al.
Bone Marrow Transplantation|April 12, 2019
Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donorsLori Wiener, Jennifer A Hoag, Wendy Pelletier, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
JAMA Oncology|December 13, 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development StudyEhab Atallah, Brent Logan, Min Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Blood and marrow transplant clinical trials network state of the Science Symposium 2014Frederick R Appelbaum, Claudio Anasetti, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Transplantation and Cellular Therapy|October 10, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research AnalysisNosha Farhadfar, Stephanie Bo-Subait, Gabrielle Schmidt, et al.
British Journal of Haematology|April 7, 2009
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantationVoravit Ratanatharathorn, Brent Logan, Dan Wang, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Bone Marrow Transplantation|November 20, 2019
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adultsNavneet S Majhail, Lih-Wen Mau, Pintip Chitphakdithai, et al.
Transplantation and Cellular Therapy|April 6, 2021
Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell DonationsSandhya R Panch, Brent Logan, Jennifer A Sees, et al.
Blood|December 15, 2018
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseasesMonica S Thakar, Larisa Broglie, Brent Logan, et al.
Bone Marrow Transplantation|April 12, 2019
Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donorsLori Wiener, Jennifer A Hoag, Wendy Pelletier, et al.
Pageof 10